Physician profile
Raymond Thal
NPI 1366425753
$779,272.15
in general payments reported to CMS, 2019-2025
11 companies · $33.57 in 2025
The $33.57 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304K · 2020: $231K · 2021: $141K · 2022: $62K · 2023: $41K · 2024: $32.61 · 2025: $33.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $41K · Food and Beverage: $112 · Education: $21.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $40,570.15 |
| Food and Beverage | $112.08 |
| Education | $21.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $742,960.84 | 2019-2023 | Bioknotless Ethibond, Versalok Orthocord, Lupine Orthocord |
| Maruho Medical, INC. | $32,532.17 | 2019-2022 | |
| Responsive Arthroscopy INC | $3,300.00 | 2020 | |
| Medical Device Business Services, INC. | $173.58 | 2019-2025 | Healix Knotless Peek |
| Depuy Synthes Sales INC. | $123.19 | 2019-2024 | Orthovisc, Monovisc, Peak |
| Pacira Therapeutics, INC. | $53.01 | 2019-2020 | |
| Ossio INC | $45.90 | 2023 | |
| Siemens Medical Solutions USA, INC. | $25.78 | 2022 | |
| Vericel Corporation | $21.37 | 2023 | Maci |
| Pacira Pharmaceuticals Incorporated | $19.26 | 2019 | |
| Smith+Nephew, INC. | $17.05 | 2025 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Thal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.